Shi, Tianshu <br/><br/>
Fenofibrate decreases the bone quality by down regulating Runx2 in high-fat-diet induced Type 2 diabetes mellitus mouse model.  [electronic resource] 

 -  Lipids in health and disease  Oct 2017 
 - 201 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-511X 
<br/><br/><label>Standard No.: </label>10.1186/s12944-017-0592-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Density--drug effects<br/>Caspase 3--genetics<br/>Collagen Type I--genetics<br/>Core Binding Factor Alpha 1 Subunit--antagonists & inhibitors<br/>Diabetes Mellitus, Type 2--etiology<br/>Diet, High-Fat--adverse effects<br/>Disease Models, Animal<br/>Dyslipidemias--etiology<br/>Fenofibrate--adverse effects<br/>Gene Expression Regulation<br/>Humans<br/>Hypolipidemic Agents--adverse effects<br/>Mice<br/>Osteoblasts--drug effects<br/>Osteocalcin--genetics<br/>Porosity--drug effects<br/>Primary Cell Culture<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>Signal Transduction<br/>X-Ray Microtomography